Literature DB >> 31754831

Now a Nobel gas: oxygen.

Joachim Fandrey1, Johannes Schödel2, Kai-Uwe Eckardt3, Dörthe M Katschinski4, Roland H Wenger5.   

Abstract

The recent bestowal of the Nobel Prize 2019 in Physiology or Medicine to Gregg L. Semenza, Sir Peter J. Ratcliffe, and William G. Kaelin Jr. celebrates a series of remarkable discoveries that span from the physiological research question on how oxygen deficiency (hypoxia) induces the red blood cell forming hormone erythropoietin (Epo) to the first clinical application of a novel family of Epo-inducing drugs to treat patients suffering from renal anemia. This review looks back at the most important findings made by the three Nobel laureates, highlights current research trends, and sheds an eye on future perspectives of hypoxia research, including emerging and potential clinical applications.

Entities:  

Keywords:  Erythropoietin; High altitude; Hypoxia; Oxygen sensing; Protein hydroxylation; von Hippel-Lindau

Mesh:

Substances:

Year:  2019        PMID: 31754831     DOI: 10.1007/s00424-019-02334-8

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  160 in total

1.  The regulated expression of erythropoietin by two human hepatoma cell lines.

Authors:  M A Goldberg; G A Glass; J M Cunningham; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Influence of serum hepatitis on haemoglobin level in patients on regular haemodialysis.

Authors:  A J Kolk-Vegter; E Bosch; A M van Leeuwen
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

3.  Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult.

Authors:  Melanie Vogler; Anke Zieseniss; Amke R Hesse; Elif Levent; Malte Tiburcy; Eva Heinze; Nicolai Burzlaff; Gunnar Schley; Kai Uwe Eckardt; Carsten Willam; Dörthe M Katschinski
Journal:  Pflugers Arch       Date:  2015-01-13       Impact factor: 3.657

4.  Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway.

Authors:  J B Hogenesch; W K Chan; V H Jackiw; R C Brown; Y Z Gu; M Pray-Grant; G H Perdew; C A Bradfield
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

Review 5.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

6.  Differential expression of lacZ in the liver and kidney of transgenic mice carrying chimeric lacZ-erythropoietin gene constructs with or without its 1.2 kb 3'-flanking sequence.

Authors:  M A Haidar; F Loya; Y Yang; H Lin; A Glassman; M J Keating; E Goldwasser; M Albitar
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

Review 7.  Erythropoietin.

Authors:  Roland H Wenger; Armin Kurtz
Journal:  Compr Physiol       Date:  2011-10       Impact factor: 9.090

8.  Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.

Authors:  Keiichi Kondo; Jeff Klco; Eijiro Nakamura; Mirna Lechpammer; William G Kaelin
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

9.  Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.

Authors:  Johannes Schödel; Chiara Bardella; Lina K Sciesielski; Jill M Brown; Chris W Pugh; Veronica Buckle; Ian P Tomlinson; Peter J Ratcliffe; David R Mole
Journal:  Nat Genet       Date:  2012-03-11       Impact factor: 38.330

10.  Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction.

Authors:  Amaya Ortiz-Barahona; Diego Villar; Nuria Pescador; Jorge Amigo; Luis del Peso
Journal:  Nucleic Acids Res       Date:  2010-01-08       Impact factor: 16.971

View more
  16 in total

1.  Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease.

Authors:  Volker H Haase
Journal:  Kidney Int Suppl (2011)       Date:  2021-03-18

Review 2.  Functional RNA Dynamics Are Progressively Governed by RNA Destabilization during the Adaptation to Chronic Hypoxia.

Authors:  Rebekka Bauer; Sofie Patrizia Meyer; Karolina Anna Kloss; Vanesa Maria Guerrero Ruiz; Samira Reuscher; You Zhou; Dominik Christian Fuhrmann; Kathi Zarnack; Tobias Schmid; Bernhard Brüne
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

Review 3.  The effect of HIF on metabolism and immunity.

Authors:  Cormac T Taylor; Carsten C Scholz
Journal:  Nat Rev Nephrol       Date:  2022-06-20       Impact factor: 42.439

4.  Analysis of the Hypoxic Response in a Mouse Cortical Collecting Duct-Derived Cell Line Suggests That Esrra Is Partially Involved in Hif1α-Mediated Hypoxia-Inducible Gene Expression in mCCDcl1 Cells.

Authors:  Anna Keppner; Darko Maric; Ilaria Maria Christina Orlando; Laurent Falquet; Edith Hummler; David Hoogewijs
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

5.  The hypoxia response pathway promotes PEP carboxykinase and gluconeogenesis in C. elegans.

Authors:  Mehul Vora; Stephanie M Pyonteck; Tatiana Popovitchenko; Tarmie L Matlack; Aparna Prashar; Nanci S Kane; John Favate; Premal Shah; Christopher Rongo
Journal:  Nat Commun       Date:  2022-10-18       Impact factor: 17.694

Review 6.  Carbon dioxide-dependent signal transduction in mammalian systems.

Authors:  D E Phelan; C Mota; C Lai; S J Kierans; E P Cummins
Journal:  Interface Focus       Date:  2021-02-12       Impact factor: 3.906

Review 7.  Hypoxia-dependent signaling in perioperative and critical care medicine.

Authors:  Kiichi Hirota
Journal:  J Anesth       Date:  2021-05-18       Impact factor: 2.078

Review 8.  HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review.

Authors:  Kiichi Hirota
Journal:  Biomedicines       Date:  2021-04-24

Review 9.  Activation of AMPK under Hypoxia: Many Roads Leading to Rome.

Authors:  Franziska Dengler
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

Review 10.  Mechanisms controlling bacterial infection in myeloid cells under hypoxic conditions.

Authors:  Inaya Hayek; Valentin Schatz; Christian Bogdan; Jonathan Jantsch; Anja Lührmann
Journal:  Cell Mol Life Sci       Date:  2020-10-30       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.